PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON AND RECOMBINANT INTERLEUKIN-2 IN METASTATIC BREAST-CANCER

被引：3
|
作者：
WALTERS, RS
THERIAULT, RL
HOLMES, FA
ESPARZA, L
HORTOBAGYI, GN
机构：
[1] Department of Breast and Gynecologic Medical Oncology, Division of Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
来源：
JOURNAL OF IMMUNOTHERAPY | 1994年 / 16卷 / 04期
关键词：
INTERFERON; INTERLEUKIN-2; METASTATIC BREAST CANCER;
D O I：
10.1097/00002371-199411000-00008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ten patients with metastatic breast cancer were treated with a combination of recombinant alpha-interferon and recombinant interleukin-2. The toxicity of treatment was considerable, including one death on therapy. No objective responses were seen.
引用
收藏
页码：303 / 305
页数：3
相关论文
共 50 条
  • [1] Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer
    Walters, RS
    Theriault, RL
    Booser, DJ
    Esparza, L
    Hortobagyi, GN
    JOURNAL OF IMMUNOTHERAPY, 1995, 18 (03): : 185 - 187
  • [2] TREATMENT OF PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERFERON-ALPHA-2B AND CONTINUOUS-INFUSION OF RECOMBINANT INTERLEUKIN-2 - A PHASE-II STUDY
    MORANT, R
    RICHNER, J
    AAPRO, M
    PALMER, PA
    SENN, HJ
    ONKOLOGIE, 1994, 17 (03): : 254 - 260
  • [3] A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN HEAD AND NECK-CANCER
    SCHANTZ, SP
    DIMERY, I
    LIPPMAN, SM
    CLAYMAN, GL
    PELLEGRINO, C
    MORICE, R
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (03) : 217 - 223
  • [4] A PHASE-II STUDY OF RECOMBINANT INTERLEUKIN-2 WITH OR WITHOUT RECOMBINANT INTERFERON-BETA IN NON-HODGKINS-LYMPHOMA - A STUDY OF THE CANCER AND LEUKEMIA GROUP-B
    DUGGAN, DB
    SANTARELLI, MT
    ZAMKOFF, K
    LICHTMAN, S
    ELLERTON, J
    COOPER, R
    POIESZ, B
    ANDERSON, JR
    BLOOMFIELD, CD
    PETERSON, BA
    GOTTLIEB, AJ
    JOURNAL OF IMMUNOTHERAPY, 1992, 12 (02): : 115 - 122
  • [5] Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a - Implications for the treatment of patients with metastatic melanoma
    Eton, O
    Talpaz, M
    Lee, KH
    Rothberg, JM
    Brell, JM
    Benjamin, RS
    CANCER, 1996, 77 (05) : 893 - 899
  • [6] INTERFERON-ALPHA AND INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC MELANOMA - COMPARISON OF 2 PHASE-II TRIALS
    KEILHOLZ, U
    SCHEIBENBOGEN, C
    TILGEN, W
    BERGMANN, L
    WEIDMANN, E
    SEITHER, E
    RICHTER, M
    BRADO, B
    MITROU, PS
    HUNSTEIN, W
    CANCER, 1993, 72 (02) : 607 - 614
  • [7] TREATMENT OF METASTATIC COLORECTAL-CANCER PATIENTS WITH 5-FLUOROURACIL IN COMBINATION WITH RECOMBINANT SUBCUTANEOUS HUMAN INTERLEUKIN-2 AND ALPHA-INTERFERON
    ATZPODIEN, J
    KIRCHNER, H
    HANNINEN, EL
    MENZEL, T
    DECKERT, M
    FRANZKE, A
    SCHOMBURG, A
    POLIWODA, H
    ONCOLOGY, 1994, 51 (03) : 273 - 275
  • [8] TREATMENT OF ADVANCED RENAL-CELL CANCER WITH SEQUENTIAL INTRAVENOUS RECOMBINANT INTERLEUKIN-2 AND SUBCUTANEOUS ALPHA-INTERFERON
    BESANA, C
    BORRI, A
    BUCCI, E
    CITTERIO, G
    DILUCCA, G
    FORTIS, C
    MATTEUCCI, P
    TOGNELLA, S
    TRESOLDI, M
    BAIOCCHI, C
    LANDONIO, G
    GHISLANDI, E
    RUGARLI, C
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1292 - 1298
  • [9] Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study
    M J Allen
    M Vaughan
    A Webb
    S Johnston
    P Savage
    T Eisen
    S Bate
    J Moore
    R Ahern
    M E Gore
    British Journal of Cancer, 2000, 83 : 980 - 985
  • [10] LYMPHOBLASTOID INTERFERON IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    NASO, C
    SIMONI, C
    MERLINI, L
    ROSSO, M
    PRONZATO, P
    REPETTO, L
    GARDIN, G
    ROSSO, R
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (04) : 258 - 261
12345